Industries > Pharmaceutical/Biotech | SupplyChainBrain
Webinars
Podcasts
Videos
Events
Subscribe
Sign In
Logistics
Air Cargo
All Logistics
Facility Location Planning
Freight Forwarding/Customs Brokerage
Global Gateways
Global Logistics
Last Mile Delivery
Logistics Outsourcing
LTL/Truckload Services
Ocean Transportation
Parcel & Express
Rail & Intermodal
Reverse Logistics
Service Parts Management
Transportation & Distribution
Technology
All Technology
Artificial Intelligence
Cloud & On-Demand Systems
Data Management (Big Data/IoT/Blockchain)
ERP & Enterprise Systems
Forecasting & Demand Planning
Global Trade Management
Inventory Planning/Optimization
Product Lifecycle Management
Robotics
Sales & Operations Planning
SC Finance & Revenue Management
SC Planning & Optimization
Supply Chain Visibility
Transportation Management
General SCM
Business Strategy Alignment
Customer Relationship Management
Education & Professional Development
Global Supply Chain Management
Global Trade & Economics
Green Energy
HR & Labor Management
Quality & Metrics
Regulation & Compliance
Sourcing/Procurement/SRM
SC Security & Risk Mgmt
Supply Chains in Crisis
Sustainability & Corporate Social Responsibility
Warehousing
All Warehouse Services
Conveyors & Sortation
Lift Trucks & AGVs
Order Management & Fulfillment
Packaging
RFID, Barcode, Mobility & Voice
Warehouse Automation
Warehouse Management Systems
Industries
Aerospace & Defense
Apparel
Automotive
Chemicals & Energy
Consumer Packaged Goods
E-Commerce/Omni-Channel
Food & Beverage
Healthcare
High-Tech/Electronics
Industrial Manufacturing
Pharmaceutical/Biotech
Retail
Think Tank
Pharmaceutical/Biotech: Page 54
Nafta by Any Other Name Is Just Fine With Corporate America
The sky isn’t falling. That’s the message coming from Corporate America after President Trump reached a deal to revise the North American Free Trade Agreement.
Here’s What’s in the New Nafta
There’s a lot to digest in the new trade agreement that the United States, Mexico and Canada, starting with a name change.
Blockchain Hype May Finally Turn Into Reality in Pharmaceuticals
Blockchain believers have delivered little more than hype, mostly failing to get it deployed outside the cryptocurrency space where the technology was developed. But a little-noticed U.S. law could change that, bringing the ledger system to the pharmaceutical business.
Companies Stockpile Drugs, Chocolate as They Brace for ‘Hard’ Brexit
Some of the world’s biggest companies are drawing up plans for the unplannable: a March divorce between Britain and the European Union, in which even some basic parameters have yet to be hammered out.
When Your Prescription Drug Is Tainted With a Chemical 'Used to Make Rocket Fuel'
Wayne Pearl, like millions of people with high blood pressure, takes the widely prescribed generic drug valsartan.
Hospitals Are Fed Up With Drug Companies, So They're Starting Their Own
A group of major American hospitals, battered by price spikes on old drugs and long-lasting shortages of critical medicines, has launched a not-for-profit generic drug company, Civica Rx, to take some control over the drug supply.
Pfizer's Costly Divorce: Pharma Giant Says Brexit Will Cost It $100M
European companies aren’t alone in their Brexit pain. Pfizer, the U.S.-based drug behemoth, says its costs for dealing with the upcoming split will reach $100m.
Supply Chain Delivers Healthcare Value in the Real World
As any supply chain professional knows, sourcing is a critical element of effective procurement.
Five Emerging Tech Trends That Blur the Lines Between Human and Machine
The 35 must-watch technologies represented on the Gartner Inc. Hype Cycle for Emerging Technologies, 2018 revealed five distinct emerging technology trends that will blur the lines between humans and machines.
Big Tech's New Alliance Is Good News for the Health of A.I.
Some of the biggest tech giants Monday agreed to build health care products that use a common set of standards in order to make it easier to share medical data across hospitals. What’s more, these are open standards and specifications aimed at encouraging “frictionless data exchange.”
Regeneron’s Billionaire Founder Battles the Drug Pricing System
Sipping a lemon-flavored VitaminWater at a sprawling complex of laboratories and offices in Tarrytown, New York, Leonard Schleifer, the 66-year-old cofounder of Regeneron Pharmaceuticals, is, as usual, criticizing the pricing practices of other drug companies. (He once told the chief executive of Pfizer: "You're not entitled to a fraction of the GDP.")
Podcast | Can Big Data Get Too Big?
Are businesses surfing the wave of big data? Or are they drowning in it?
Previous Page
Page 54 of 336
Next Page
Sign me up!
Receive the latest supply chain trends, news and analysis from SupplyChainBrain.
Email Address
*
Sign Up
Featured Product
Case Studies
Case Studies
How a Leading U.S. Floral Distribution Company Reduced Warehouse Labor Costs by 45% with RFID
Case Studies
Recycled Tagging Fasteners: Small Changes Make a Big Impact
Case Studies
Enhancing High-Value Electronics Shipment Security with Tive's Real-Time Tracking
Case Studies
Moving Robots Site-to-Site